Issue 1/2020
Content (28 Articles)
European Association for the Study of Diabetes 2019 Conference: Podcast Overview of the Conference
Uazman Alam, Shazli Azmi
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
Anastasia Erythropoulou-Kaltsidou, Georgios Polychronopoulos, Konstantinos Tziomalos
Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment
Viswanathan Mohan, Kamlesh Khunti, Siew P. Chan, Fadlo F. Filho, Nam Q. Tran, Kaushik Ramaiya, Shashank Joshi, Ambrish Mithal, Maïmouna N. Mbaye, Nemencio A. Nicodemus Jr., Tint S. Latt, Linong Ji, Ibrahim N. Elebrashy, Jean C. Mbanya
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora
Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)
Aslam Amod, John B. Buse, Darren K. McGuire, Thomas R. Pieber, Rodica Pop-Busui, Richard E. Pratley, Bernard Zinman, Marco Bo Hansen, Ting Jia, Thomas Mark, Neil R. Poulter
The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
Yu-peng Li, Zhong-qing Yan, Li-ping Han, Ai-li Yin, Jin-yong Xu, Ya-ran Zhai, Sai Hao, Lin Zhang, Yun Xie
The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies
Mark Evans, Zoë Welsh, Sara Ells, Alexander Seibold
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
Paola Ponzani, Cesare Berra, Alessandra Di Lelio, Paola Del Sindaco, Chiara Di Loreto, Francesco Reggiani, Giuseppe Lucisano, Maria Chiara Rossi
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
Fumiko Yamamoto, Yuriko Unno, Tomoo Okamura, Rie Ikeda, Kaori Ochiai, Naoyuki Hayashi
Experiences of Attending Group Education to Support Insulin Initiation in Type 2 Diabetes: A Qualitative Study
Rebecca Upsher, Maya Allen-Taylor, Ilse Reece, Mark Chamley, Khalida Ismail, Angus Forbes, Kirsty Winkley
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study
Hitoshi Ishii, Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study
Pierre Gourdy, Amar Bahloul, Zahra Boultif, Didier Gouet, Bruno Guerci
Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient’s Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data
Diana Šimonienė, Aksana Platūkiene, Edita Prakapienė, Lina Radzevičienė, Džilda Veličkiene
Comparative Effects of Three Kinds of Bariatric Surgery: A Randomized Case–Control Study in Obese Patients
Dan Luo, Qingling Yang, Li Zhou, Haibo Wang, Feng Li, Hailong Ge, He Huang, Jian Liu, Yanjun Liu
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting
Cheli Melzer-Cohen, Gabriel Chodick, Shiran Naftelberg, Naim Shehadeh, Avraham Karasik
Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site
Toshihiko Aranishi, Yukiko Nagai, Yasushi Takita, Shuyu Zhang, Rimei Nishimura
Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study
Tam Dang-Tan, Pravin S. Kamble, Yunus Meah, Cory Gamble, Rahul Ganguly, Libby Horter
Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances
María J. Peláez-Jaramillo, Natalia Valencia-Enciso, Allison A. Cárdenas-Mojica, Paula V. Gaete, Eitan A. Scher-Nemirovsky, Luisa F. Gómez-Arango, Daniel Colmenares-Araque, Camilo A. Castro-López, Eddy Betancourt-Villamizar, Jesús Jaimes-Madrigal, Carlos A. Alvarez, Mario A. Jiménez-Mora, Pedro J. Quiroga-Padilla, Danna K. Puerto-Baracaldo, Carlos O. Mendivil
Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
Yulong Chen, Quanmin Li, Ying Han, Hongmei Ji, Mingjun Gu, Rongwen Bian, Weiguang Ding, Jian Cheng, Yiming Mu
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Stephen C. Bain, Brian B. Hansen, Samuel J. P. Malkin, Solomon Nuhoho, William J. Valentine, Barrie Chubb, Barnaby Hunt, Matthew Capehorn
Three European Retrospective Real-World Chart Review Studies to Determine the Effectiveness of Flash Glucose Monitoring on HbA1c in Adults with Type 2 Diabetes
Jens Kröger, Peter Fasching, Hélène Hanaire
Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results
Sandra Keutmann, Stephanie Zylla, Mathilde Dahl, Nele Friedrich, Rüdiger Landgraf, Lutz Heinemann, Anders Kallner, Matthias Nauck, Astrid Petersmann
Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis
Ádám G. Tabák, John Anderson, Pablo Aschner, Minzhi Liu, Aramesh Saremi, Peter Stella, Francisco J. Tinahones, Carol Wysham, Juris J. Meier
Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy
Louis S. Matza, Beatrice Osumili, Katie D. Stewart, Magaly Perez-Nieves, Jessica Jordan, Giovanni Biricolti, Ester Romoli, Serena Losi, Silvia Del Santo, Erik Spaepen, Gordon Parola, Hayley Karn, Kristina S. Boye
IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy
Hirotaka Watada, Bue F. Ross Agner, Ankur Doshi, Lars Bardtrum, Mattis Flyvholm Ranthe, Liana K. Billings
The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
Nikolaos Papanas, Kalliopi Pafili, Maria Demetriou, Stella Papachristou, Soultana Kyroglou, Dimitrios Papazoglou, Efstratios Maltezos
Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial
Cheol Son, Masato Kasahara, Tomohiro Tanaka, Noriko Satoh-Asahara, Toru Kusakabe, Kunihiro Nishimura, Yoshihiro Miyamoto, Shu Kasama, Kiminori Hosoda
INtegration of care for reaching targetS In Diabetic patiEnts: Design of the INSIDE Study
Marco Comaschi, Andrea Di Lenarda, Gerardo Medea, Alberto Aglialoro, Domenico Cucinotta, Michele Gulizia, Giacomo Vespasiani, Guerrino Zuin, Antonio Nicolucci, Federico Spandonaro, Aldo Pietro Maggioni